Opposition to prescription drug price controls in the Inflation Reduction Act

Moore opposes the government-control approach to prescription drug pricing that he attributes to the Inflation Reduction Act. He favors addressing drug prices through a competitive marketplace instead.

Context: His criticism refers to the prescription drug pricing approach in the Inflation Reduction Act.

In their own words

Instead of promoting egregious government control of prescription drug pricing

The source

Blake D. Moore: Healthcare

Published: Original date not established; campaign context manually checked
Retrieved: 11/10/2026